CD163 and breast cancer: In breast cancer patients who received chemotherapy, we found that the average number of communicating CD163+ TAMs had the largest effect size (hazard ratio) in the multivariable Cox model for PFS adjusted for known significant clinicopathological risk factors and corrected for optimistic bias associated with dichotomization.